SillaJen, Inc. (215600.KQ)
KRW 2565.0
(0.79%)
KRW 2565.0
(0.79%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -179.98 KRW | 17.17% |
| 2022 | -221.44 KRW | -31.97% |
| 2021 | -167.79 KRW | 72.86% |
| 2020 | -618.29 KRW | 58.26% |
| 2019 | -1481.28 KRW | -100.85% |
| 2018 | -737.49 KRW | 7.27% |
| 2017 | -795.30 KRW | 45.24% |
| 2016 | -1452.28 KRW | -60.19% |
| 2015 | -906.59 KRW | -681.54% |
| 2014 | -116.00 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -45.59 KRW | 15.01% |
| 2024 Q2 | -64.07 KRW | -40.54% |
| 2023 Q3 | -48.06 KRW | -1.24% |
| 2023 FY | - KRW | 17.17% |
| 2023 Q4 | -53.64 KRW | -11.61% |
| 2023 Q1 | -32.44 KRW | 56.43% |
| 2023 Q2 | -47.47 KRW | -46.33% |
| 2022 Q2 | -43.94 KRW | 16.38% |
| 2022 FY | - KRW | -31.97% |
| 2022 Q1 | -52.55 KRW | 22.97% |
| 2022 Q4 | -74.45 KRW | -36.33% |
| 2022 Q3 | -54.61 KRW | -24.28% |
| 2021 Q2 | 20.95 KRW | 131.0% |
| 2021 Q4 | -68.22 KRW | -35.92% |
| 2021 FY | - KRW | 72.86% |
| 2021 Q1 | -67.59 KRW | -2.08% |
| 2021 Q3 | -50.19 KRW | -339.57% |
| 2020 FY | - KRW | 58.26% |
| 2020 Q4 | -66.21 KRW | 67.47% |
| 2020 Q3 | -203.55 KRW | 18.87% |
| 2020 Q2 | -250.88 KRW | -70.11% |
| 2020 Q1 | -147.48 KRW | 10.1% |
| 2019 Q3 | -219.00 KRW | 78.14% |
| 2019 Q1 | -218.06 KRW | -33.65% |
| 2019 FY | - KRW | -100.85% |
| 2019 Q4 | -164.05 KRW | 25.09% |
| 2019 Q2 | -1002.00 KRW | -359.51% |
| 2018 Q2 | -194.26 KRW | 6.2% |
| 2018 Q4 | -163.16 KRW | 34.11% |
| 2018 Q3 | -247.64 KRW | -27.48% |
| 2018 FY | - KRW | 7.27% |
| 2018 Q1 | -207.09 KRW | 16.71% |
| 2017 Q2 | -295.00 KRW | -58.63% |
| 2017 FY | - KRW | 45.24% |
| 2017 Q1 | -185.97 KRW | 74.19% |
| 2017 Q4 | -248.65 KRW | -70.31% |
| 2017 Q3 | -146.00 KRW | 50.51% |
| 2016 Q4 | -720.48 KRW | -150.17% |
| 2016 Q2 | -226.70 KRW | -28.81% |
| 2016 Q1 | -176.00 KRW | 63.36% |
| 2016 FY | - KRW | -60.19% |
| 2016 Q3 | -288.00 KRW | -27.04% |
| 2015 Q3 | -325.00 KRW | 42.53% |
| 2015 Q4 | -480.31 KRW | -47.79% |
| 2015 Q2 | -565.56 KRW | -4.01% |
| 2015 Q1 | -543.77 KRW | -230.38% |
| 2015 FY | - KRW | -681.54% |
| 2014 FY | - KRW | 0.0% |
| 2014 Q2 | -36.11 KRW | 79.5% |
| 2014 Q3 | -345.00 KRW | -855.41% |
| 2014 Q4 | 417.07 KRW | 220.89% |
| 2014 Q1 | -176.15 KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Co., Ltd. | -1559.61 KRW | 88.46% |
| iNtRON Biotechnology, Inc. | -292.11 KRW | 38.386% |
| BINEX Co., Ltd. | 151.04 KRW | 219.16% |
| Bioneer Corporation | -410.19 KRW | 56.123% |
| Anterogen.Co.,Ltd. | -291.93 KRW | 38.348% |
| MEDIPOST Co., Ltd. | 287.00 KRW | 162.711% |
| CrystalGenomics, Inc. | -661.00 KRW | 72.772% |
| Helixmith Co., Ltd | -1543.76 KRW | 88.341% |
| Chabiotech Co.,Ltd. | -149.80 KRW | -20.147% |
| Medy-Tox Inc. | 1456.65 KRW | 112.356% |
| Peptron, Inc. | -773.61 KRW | 76.735% |
| Amicogen, Inc. | -583.58 KRW | 69.159% |
| Genexine, Inc. | -1652.14 KRW | 89.106% |
| HLB Therapeutics Co.,Ltd. | -32.12 KRW | -460.336% |
| LegoChem Biosciences, Inc. | -2595.00 KRW | 93.064% |
| ALTEOGEN Inc. | -65.27 KRW | -175.747% |
| PharmaResearch Co., Ltd. | 7502.00 KRW | 102.399% |
| JETEMA, Co., Ltd. | 783.21 KRW | 122.98% |
| OliX Pharmaceuticals,Inc | -1323.81 KRW | 86.404% |
| Genomictree Inc. | -391.00 KRW | 53.969% |
| MedPacto, Inc. | -1664.87 KRW | 89.19% |
| D&D Pharmatech | 409.19 KRW | 143.984% |
| EASY BIO,Inc. | 455.00 KRW | 139.556% |
| GI Innovation, Inc. | -1285.69 KRW | 86.001% |